No início desta semana, Titanique e Beaches: The Musical anunciaram em rápida sucessão que irão ocupar, respectivamente, os teatros St. James e Majestic, cada um por um período limitado nesta ...
Novo Nordisk has won the race to secure approval from the U.S. Food and Drug Administration for the first weight-loss drug to be administered orally. Jules Rimmer is a markets reporter in ...
Filipe La Feria recebeu este fim de semana a medalha de mérito cultural. O momento aconteceu antes da estreia de um novo musical, desta vez, sobre Carmen Miranda. Informações preocupantes sobre Putin ...
A partir de 8 de janeiro, o Teatro Claro Mais RJ recebe a nova temporada de ‘Djavan – O Musical’, produção da Turbilhão de Ideias, com realização da Nove Produções, apresentada pelo Ministério da ...
The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug. The Wegovy pill, as it’s called, is first oral version of a GLP-1 drug that ...
Novo Nordisk wins FDA approval for Wegovy in a pill, introducing first oral GLP-1 option for obesity
After ushering in a new era of obesity treatment with its GLP-1 medicine Wegovy earlier in the decade, Novo Nordisk is making history again with the first FDA approval of a GLP-1 pill for weight loss.
Matheus e Kauan preparam-se para lançar um novo projeto musical, gravado em estúdio, poucos dias depois de terem agitado as redes sociais com um vídeo enigmático que levantou rumores sobre o fim da ...
FDA approves Novo Nordisk's weight-loss pill Novo aims to regain market share from Eli Lilly Pill broadens potential patient pool The pill is 25 milligrams of semaglutide, the same active ingredient ...
The pole position in the GLP-1 weight loss space is currently held by Eli Lilly. Novo Nordisk was the early leader, showing that being first doesn't always mean you stay at the head of the pack.
Novo Nordisk offers compelling value, trading at a 32% discount to fair value with a 3.6% yield and robust dividend growth. NVO's semaglutide-based drugs drive 74% of sales, but pipeline innovation, ...
Dec 18 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Thursday it had filed a marketing application with the U.S. Food and Drug Administration for CagriSema, its once-weekly ...
Novo Nordisk NOVO.B1.08%increase; green up pointing triangle filed for U.S. Food and Drug Administration approval of CagriSema, a once-weekly shot that combines two compounds to treat obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback